Welcome to the USF Health
Assistant Professor Biomedical, College of Medicine Cardiology
- Cancer-treatment induced cardiotoxicity is the leading cause of the mortality in more than 15.5 million cancer survivors. Moreover, the cardiotoxicity is the reason cancer patients could not continue receiving treatment. Research of my lab is focused on understanding the mechanism of cancer-treatment related cardiotoxicity through integrated omics-based approach and validating nano-scale platform treatment strategies to mitigate cardiotoxocity for cancer patients and survivors. My laboratory provides a multidisciplinary basic and applied research environment and training venue with a translational emphasis. Specific research focuses include:
- 1. Mitigate cancer-treatment related vascular damage with anti-thrombotic interventions.
- 2. Target the Nox2/4-oxidative stress axis for predicting and alleviating cardiomyocyte toxicity caused by anthracyclines.
- 3. Target the inflammation signaling pathways for predicting and alleviating cardiotoxicity caused by immune checkpoint inhibitors.
Assistant Professor, Molecular Pharmacology and Physiology
- Our research is focused on elucidating the role of non-coding RNA in vascular diseases. We are currently working on two different areas: 1) use non-coding RNA to confer tissue specificity to novel therapeutics for vascular diseases, including coronary artery stent restenosis. 2) Study the role of microRNA in infantile hemangioma
USF Health Institute News
//www.youtube.com/watch?v=wbGCYIyMlEE TAMPA, Fla. (August 30, 2017) — Pacemakers help people live longer, active lives. They’re also often worn for decades at a time. But a pacemaker’s wiring could get infected, and the signs are too similar to typical ailments. It’s something 68-year-old Ri … [read more]
Tampa, FL (July 5, 2017) – Tampa General Hospital and the USF Health Morsani College of Medicine are creating a new model for advanced organ transplantation. Noted transplant physician Dr. David Weill has been named director of the new Institute for Advanced Organ Disease and Transplantation, which … [read more]
USF Health researcher Mack Wu, MD, studies what happens when the microvascular endothelial barrier controlling blood-tissue exchange is compromised during ischemia-reperfusion injury, a condition that can lead to irreversible tissue damage. He also investigates the molecular control of gut permeabil … [read more]